Significant disparities in treatment for locally advanced pancreatic cancer

Treatment trends for locally advanced pancreatic cancer reveal that 67.67% of patients received primarily chemotherapy, with notable improvement in surgical resection rates over time. However, 41.19% also received radiation, yet many patients went untreated or did not receive guideline-recommended treatment (GRT). Socioeconomic factors like race, education, and insurance significantly influenced access to care and overall survival rates, highlighting persistent inequalities despite advancements in treatment options.